The adverse drug reactions reported in these tables are those events that occurred in 0.1% or more of patients treated with MIRAPEXIN and were reported significantly more often in patients taking MIRAPEXIN than placebo, or where the event was considered clinically relevant.
Nendes tabelites esitatud ravimi kõrvaltoimete hulka on arvatud need juhtumid, mida täheldati vähemalt 0, 1% - l MIRAPEXIN’ i saanud patsientidest ja mida esines tunduvalt sagedamini MIRAPEXIN’ i kui platseebo puhul või kui kõrvaltoimet peeti kliiniliselt oluliseks.